BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Quarterly EPS Estimate At $-0.24

0

The EPS estimate of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) for period quarter ended 2016-12-31 is $-0.24.

The EPS estimates posted seven and 30 days ago were $-0.24 and $-0.24 correspondingly. Even though the EPS forecasts stated 60 and 90 days ago were $-0.24 and $-0.24 respectively. The deviation in EPS forecast from 7 days ago is 0%.

The EPS revisions on positive side in the last 7 days were 0 and downside revisions were 0. The number of positive revisions of EPS in the last 30 and 60days were 0 and 1 respectively, while for 90 and 120 days, the count was 1 and 1.

The number of negative revisions of EPS in the last 30 and 60days were 0 and 2 while for 90 and 120 days, the count was 2 and 2.

EPS revisions upgrade and downgrade in the last 18 days were 2 and 3 correspondingly.

Earnings Surprises

The mean EPS forecast immediately prior to the actual earnings release for the period ended 2 is $-0.24 based on 6 EPS estimates. The EPS reported on 2016-08-04 was $-0.22. The EPS surprise came at $0.02, or 8.33%. The standard deviation of given EPS estimates was $0.02.

Quarterly Sales Estimates

The arithmetic mean of estimated annual sales of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is $5.22 and the median was $5.839. The estimate is reported by 4 analysts for the fiscal 2016.

The highest annual estimate is $6.484 and lowest sales target is $2.72. This results in a standard deviation of $1.75.

Almost 4 have revised sales forecast on upside over the past week and 4 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Nearly 4 have revised sales forecast on upside over the past month and 4 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Just about 4 have revised sales forecast on upside over the quarter and 4 have downgraded forecasts. The mean estimate deviation from the past week is 1.104%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 19 times, 1 visits today)